Home Healthcare Pharmaceuticals Food Allergy Market

Food Allergy Market Size, Share & Trends Analysis Report By Treatment (Antihistamines, Adrenaline, Oral Immunotherapy, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 13, 2026 | Author: Debashree B | Format:

Food Allergy Market Size

The global food allergy market size was valued at USD 40.14 billion in 2025 and is projected to grow from USD 42.27 billion in 2026 to USD 63.89 billion by 2034, registering a CAGR of 5.3% during the forecast period from 2026 to 2034. North America dominated the food allergy market with a market share of 38.4% in 2025.

The market for food allergy is growing strongly and represents a major area of growth. It offers a full range of allergy management and treatment options. Advanced testing methods, such as skin pricks and blood tests are used for the identification of food triggers in the diagnostics segment. Lifesaving epinephrine autoinjectors for severe reactions are provided in the emergency response section. The preventive segment is most promising, offering a growing choice of allergen-free food products and contributing to inclusiveness and improving the quality of life for those suffering from allergy. This market is set to grow further as individuals are empowered to control their allergies and make a success of them.

The market for food allergy is expected to grow strongly, driven by a significant increase in the number of diagnosed cases among children. The demand for improved diagnostic tools, effective treatments such as erythropoietic autoinjectors and development of allergen free food products is a result of this growth in allergy cases that creates an extensive market for companies to meet these needs.

Food Allergy Market Size

Download Free Sample Report To learn more about this report,

Food Allergy Market Growth Factors

Increasing Physician-Dispensed Cosmeceuticals’ Advantages Are Boosting the Demand

A particularly concerning trend is driving the food allergy market: the rising prevalence of food allergies, especially among children. This increase in the number of cases is translating into increased demand for different solutions at all levels of the market. For instance, according to the Asthma and Allergy Foundation of America, more than 100 million people in the U.S. experience various types of allergies each year. Common examples include seasonal allergies, eczema, and food allergies. Moreover, nearly 1 in 3 U.S. adults and more than 1 in 4 U.S. children have a seasonal allergy, eczema, or food allergy. The increasing number of allergy patients contributes to the expansion of the market, in view of the need for precise diagnostic tools and early identification of allergens, while also requiring effective emergency treatment and preventive measures such as allergen-free food options.

Increased Demand for Improved Diagnostics

A key driver of the food allergy market is the demand for better diagnostic tests. Traditional methods, such as skin prick tests, which are effective, can be time-consuming and uncomfortable. The result is that innovative and effective test methods are missing. Advances such as blood tests, which offer a more convenient and potentially more accurate way of identifying food allergy, are responding to the market. In addition, there is increasing interest in the development of home testing kits that could make it easier for people to manage their allergies proactively and enable them to take more active roles.

Market Restraining Factors

High Cost of Treatments

High costs associated with different treatments are an important obstacle to the management of food allergies. The cost of allergy testing, whether by pricking the skin or blood tests, can be high and could delay diagnosis and appropriate treatment. Even after diagnosis, medications like epinephrine auto-injectors, crucial for emergency situations, can be a significant financial burden for some families. The field of allergen-free food products may be the most important cost factor. In contrast to common foodstuffs, these specialised products are sometimes offered at a premium compared with other foods and can lead to restrictions on access for those who need them or create additional barriers in the maintenance of good nutrition.

Market Opportunity

Development of Novel Diagnostics

The market for food allergy has enormous potential due to new diagnostic developments. The accessibility and empowerment of patients to take charge of their health could be significantly improved through home-based testing kits. Moreover, noninvasive blood tests are a potentially more convenient and precise alternative to conventional methods of diagnosis, facilitating the choice of medicines and speeding up decision making. The landscape of food allergy management is expected to change with these innovations.

Advancements in Oral Immunotherapy (oit)

Oral Immunotherapy OIT is a game changer in the market for food allergy. OIT has the potential to cure and desensitize the immune system to allergens, unlike traditional medicines that treat symptoms. This implies that allergy patients are less dependent on the use of medicines, reducing healthcare costs and significantly improving their quality of life. The market has tremendous potential for further investment in OIT research and development, which could lead to a revolution in food allergy treatment.

Food Allergy Market Size By Segments

Request Customizationto receive a tailored report.

Treatment Insights

The market is segmented into antihistamines, adrenaline, oral immunotherapy, and others. Oral Immunotherapy dominates the treatment segment. The future of food allergy treatment will be dominated by oral immunotherapy (OIT). Unlike medication, it desensitizes the immune system to offer a potential cure rather than relief of symptoms. The growth of the OIT market is driven by this shift from management to treatment.

Distribution Channel Insights

The market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. Hospital pharmacy dominates the distribution channel segment. Due to two key factors, hospital pharmacies currently dominate the market for food allergy, contrary to the general distribution of medicines. First, anaphylaxis patients may need immediate access to epinephrine autoinjectors which can be provided by hospitals in severe cases. Second, specialists in hospital settings often administer and monitor OIT, a promising treatment, which requires on-site access to medicinal products.

Food Allergy Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Insights

North America is the most significant global market shareholder and is expected to expand substantially during the forecast period. The scene of food allergy in North America is growing exponentially. The market is driven by an alarming rise in allergies, especially for children. As a result, there is a demand for better diagnostics, lifesaving epinephrine for emergencies, and a wider variety of allergen-free foods. From diagnosis to delicious, safe meals, the market caters to managing food allergies across the board.

  • The United States food allergy market. The United States is likely the dominant player within North America's food allergy market due to its large population, high prevalence of allergies, and advanced medical facilities.
  • The Canadian food allergy industry. Canada's market is growing due to growing awareness of food allergies, coupled with an increase in diagnoses, which fuels demand for solutions.

These factors are estimated to drive the North American food allergy industry growth.

Asia-Pacific Food Allergy Market Trends

The Asia Pacific region is a pivotal market for the food allergy industry. The market in Asia Pacific will also be stimulated by the increasing focus of key players on expanding into new Asian markets, a large customer base and rising awareness about food allergies.

  • China food allergy industry. China is a major player due to its large population and rising disposable income, leading to increased healthcare spending and demand for allergy solutions.
  • Japan food allergy market. Japan already has a high level of awareness of food allergy and a developed healthcare infrastructure, which is expected to contribute to the growth of the market.

Thus, the factors above are estimated to boost the Asia-Pacific food allergy market growth.

North America Food Allergy Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

List of Key and Emerging Players in Food Allergy Market

  • Nutra Respiro
  • Marksans Pharma Ltd.
  • AdvaCare Pharma
  • Bayer AG
  • ALK
  • Novartis Pharmaceuticals Corporation
  • Prota Therapeutics
  • Aimmune Therapeutics
  • Aravex
  • ALS Limited

Key Industry Developments

  • June 2026: Nestlé Health Science expanded its food allergy nutrition portfolio through continued development of specialized nutritional solutions for individuals with food allergies and intolerances. The company focused on advancing medical nutrition products designed to support allergy management and improve dietary options for affected populations.
  • May 2026: DBV Technologies advanced its Viaskin™ peanut allergy immunotherapy program through continued clinical and regulatory activities. The company focused on improving non-invasive epicutaneous immunotherapy approaches using its proprietary skin patch technology to support peanut allergy treatment.
  • April 2026: ALK-Abelló expanded its allergy immunotherapy research and development activities with continued investments in diagnostic and treatment solutions for allergic diseases, including food-related allergies. The company focused on advancing precision allergy care through improved testing methods and immunotherapy technologies.
  • February 2026: Aimmune Therapeutics expanded its peanut allergy treatment initiatives following continued commercialization and development activities around PALFORZIA®, the first FDA-approved oral immunotherapy product for peanut allergy. The company focused on improving treatment accessibility and supporting healthcare providers in allergy management.

Report Scope

Market Metric Details & Data (2025-2034)
Market Size in 2025 USD 40.14 Billion
Market Size in 2026 USD 42.27 Billion
Market Size in 2034 USD 63.89 Billion
CAGR 5.3% (2026-2034)
Base Year for Estimation 2025
Historical Data2022-2024
Forecast Period2026-2034
Study Period 2022-2034
Dominant Region North America
Fastest Growing Region Asia Pacific
Key Market Players Nutra Respiro, Marksans Pharma Ltd., AdvaCare Pharma, Bayer AG, ALK
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Segments Covered By Treatment, By Distribution Channel
Geographies Covered North America, Europe, APAC, Middle East and Africa, LATAM
Countries Covered US, Canada, UK, Germany, France, Spain, Italy, Russia, Nordic, Benelux, China, Korea, Japan, India, Australia, Singapore, Taiwan, South East Asia, UAE, Turkey, Saudi Arabia, South Africa, Egypt, Nigeria, Brazil, Mexico, Argentina, Chile, Colombia

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

How big is the food allergy market?
According to Straits Research, the global food allergy market is estimated at USD 42.27 billion in 2026 and is projected to reach USD 63.89 billion by 2034, growing at a CAGR of 5.3%.
The food allergy market is projected to grow at a CAGR of 5.3% during the forecast period 2026-2034.
North America is the leading region in this market in 2026.
The leading companies operating in the food allergy market are Nutra Respiro, Marksans Pharma Ltd., AdvaCare Pharma, Bayer AG, ALK, and others.

Author's Details


Debashree B

Healthcare Lead

Debashree Bora is a Healthcare Lead with over 7 years of industry experience, specializing in Healthcare IT. She provides comprehensive market insights on digital health, electronic medical records, telehealth, and healthcare analytics. Debashree’s research supports organizations in adopting technology-driven healthcare solutions, improving patient care, and achieving operational efficiency in a rapidly transforming healthcare ecosystem.

Report Details
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
custom reports
Need a Tailored Report?
80% of our existing clients ask for tailored reports.
Request Customization
Request Sample Order Report Now

We are featured on: